Related Experiment Video
Updated: Aug 6, 2025

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
Published on: May 3, 2018
The relationship between the pan-immune-inflammation value and long-term prognoses in patients with hypertension:
Bo Wu1, Chenlu Zhang1, Shuqiong Lin2
1Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
Insights
High pan-immune-inflammation value (PIV) indicates increased risk of death in hypertensive patients. This study links elevated PIV to higher all-cause and cardiovascular mortality, highlighting its potential as a prognostic marker.
Area of Science:
- Cardiology
- Immunology
- Public Health
Background:
- Hypertension management requires better risk stratification beyond cardiovascular disease (CVD) risk.
- Immunity and inflammation significantly impact hypertension prognosis.
- The pan-immune-inflammation value (PIV) is an emerging index for assessing immune-inflammatory status.
Purpose of the Study:
- To investigate the association between PIV and long-term mortality in hypertensive patients.
- To determine if PIV can serve as a predictor for all-cause and cardiovascular mortality.
Main Methods:
- Analysis of data from the National Health and Nutrition Examination Survey (NHANES) 1999-2018.
- Inclusion of 26,781 hypertensive participants with mortality follow-up through December 31, 2019.
- Assessment of PIV's relationship with mortality using survival curves and Cox regression analysis.
Main Results:
- A significant association was found between PIV levels and long-term all-cause and cardiovascular mortality.
- Higher PIV levels were linked to an increased risk of all-cause mortality (HR: 1.37) and cardiovascular mortality (HR: 1.62).
- These associations remained significant after full adjustment for potential confounders.
Conclusions:
- Elevated PIV is a significant predictor of increased all-cause and cardiovascular mortality in hypertensive individuals.
- PIV may offer valuable insights for identifying high-risk hypertensive patients.
- Further research could explore PIV's role in guiding therapeutic strategies for hypertension.
Background:
Direct antihypertensive therapy in hypertensive patients with a high CVD risk can reduce the incidence of cardiovascular death but increase adverse cardiovascular events, so additional ways to identify hypertensive patients at high risk may be needed. Studies have shown that immunity and inflammation affect the prognoses of patients with hypertension and that the pan-immune-inflammation value (PIV) is an index to assess immunity and inflammation, but few studies have applied the PIV index to patients with hypertension.
Objective:
To explore the relationship between the PIV and long-term all-cause and cardiovascular mortality in patients with hypertension.
Method:
Data from the National Health and Nutrition Examination Survey (NHANES) 1999-2018 with a mortality follow-up through December 31, 2019, were analyzed. A total of 26,781 participants were evaluated. The patients were grouped based on PIV levels as follows: T1 group (n = 8,938), T2 group (n = 8,893), and T3 group (n = 8,950). The relationship between the PIV and long-term all-cause and cardiovascular death was assessed by survival curves and Cox regression analysis based on the NHANES recommended weights.
Result:
The PIV was significantly associated with long-term all-cause and cardiovascular mortality in patients with hypertension. After full adjustment, patients with higher PIV have a higher risk of all-cause [Group 3: HR: 1.37, 95% CI: 1.20-1.55, p < 0.001] and cardiovascular [Group 3: HR: 1.62, 95% CI: 1.22-2.15, p < 0.001] mortality.
Conclusion:
Elevated PIV was associated with increased all-cause mortality and cardiovascular mortality in hypertensive patients.
More Related Videos
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
10:11Fundus Photography as a Convenient Tool to Study Microvascular Responses to Cardiovascular Disease Risk Factors in Epidemiological Studies
Published on: October 22, 2014
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Factors affecting Blood pressure
Physiological Factors: